Tess Burleson - Net Worth and Insider Trading
Tess Burleson Net Worth
The estimated net worth of Tess Burleson is at least $246 dollars as of 2024-11-06. Tess Burleson is the Director of Salarius Pharmaceuticals Inc and owns about 160 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $246. Details can be seen in Tess Burleson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tess Burleson has not made any transactions after 2022-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tess Burleson
Tess Burleson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tess Burleson owns 1 companies in total, including Salarius Pharmaceuticals Inc (SLRX) .
Click here to see the complete history of Tess Burleson’s form 4 insider trades.
Insider Ownership Summary of Tess Burleson
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SLRX | Salarius Pharmaceuticals Inc | 2022-06-07 | director |
Tess Burleson Latest Holdings Summary
Tess Burleson currently owns a total of 1 stock. Tess Burleson owns 160 shares of Salarius Pharmaceuticals Inc (SLRX) as of June 7, 2022, with a value of $246.
Latest Holdings of Tess Burleson
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SLRX | Salarius Pharmaceuticals Inc | 2022-06-07 | 160 | 1.54 | 246 |
Holding Weightings of Tess Burleson
Tess Burleson Form 4 Trading Tracker
According to the SEC Form 4 filings, Tess Burleson has made a total of 2 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Salarius Pharmaceuticals Inc is the acquisition of 138 shares on June 7, 2022, which cost Tess Burleson around $4,986.
Insider Trading History of Tess Burleson
- 1
Tess Burleson Trading Performance
GuruFocus tracks the stock performance after each of Tess Burleson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tess Burleson is 8.87%. GuruFocus also compares Tess Burleson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tess Burleson within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tess Burleson's insider trading performs compared to the benchmark.
Tess Burleson Ownership Network
Ownership Network List of Tess Burleson
Ownership Network Relation of Tess Burleson
Tess Burleson Owned Company Details
What does Salarius Pharmaceuticals Inc do?
Who are the key executives at Salarius Pharmaceuticals Inc?
Tess Burleson is the director of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include Exec VP Finance & Interim CFO Mark J Rosenblum , director & Chief Executive Officer David J. Arthur , and Chief Financial Officer Scott Jordan .
Salarius Pharmaceuticals Inc (SLRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc (SLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc (SLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Salarius Pharmaceuticals Inc (SLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Salarius Pharmaceuticals Inc Insider Transactions
Tess Burleson Mailing Address
Above is the net worth, insider trading, and ownership report for Tess Burleson. You might contact Tess Burleson via mailing address: 2450 Holcome Blvd., Suite J-608, Houston Tx 77021.